Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Others inject BPC-157 locally and TB-500 subcutaneously at a distant site (like the abdomen)
Third-party verification is our standard
When BPC-157 is used alone, many patients feel better, return to activity, and then discover the tissue is not yet resilient
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Importantly, BPC-157 also induces expression of EGR-1 and its corepressor NAB2, forming a regulatory feedback loop that modulates the duration and amplitude of angiogenic gene transcription during wound healing
Research Base Comparison Both compounds have substantial published research bases, but with different shapes: BPC-157
US$ 28.24
US$ 20.39
US$ 27.66
US$ 20.61
US$ 20.54
US$ 27.65
US$ 28.15
